Provided by Tiger Trade Technology Pte. Ltd.

LUYE PHARMA

2.160
+0.0150.70%
Volume:88.27M
Turnover:194.02M
Market Cap:8.63B
PE:11.65
High:2.315
Open:2.210
Low:2.150
Close:2.145
52wk High:3.940
52wk Low:1.730
Shares:4.00B
HK Float Shares:4.00B
Volume Ratio:2.51
T/O Rate:2.21%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.185
ROE:4.14%
ROA:2.44%
PB:0.46
PE(LYR):11.65
PS:1.17

Loading ...

Shandong Boan Biotech shareholders adopt restricted share unit incentive scheme at AGM

Reuters
·
Jun 22

Luye Pharma Group Drug Meets Main Goal of Phase 2 Study

MT Newswires Live
·
Jun 17

Daily Insight into Hong Kong Stocks: DeepSeek Secures $50 Billion Funding, Yum China Acquires Full Ownership of Pizza Hut in Mainland China

Stock News
·
Jun 17

LUYE PHARMA's Novel Drug LY03015 Shows Positive Phase II Results in China for Tardive Dyskinesia

Stock News
·
Jun 16

Luye Pharma reports strong Phase 2 data for first-in-class TD therapy LY03015, sets stage for global Phase 3

Bulletin Express
·
Jun 16

Luye Pharma says LY03015 meets primary endpoint in China Phase 2 tardive dyskinesia trial

Reuters
·
Jun 16

TransThera Sciences names Sun Delong chief operating officer

Reuters
·
Jun 12

Luye Pharma Group's Bond Buyback Undersubscribed

MT Newswires Live
·
Jun 12

Shandong Boan Biotech licenses U.S. rights to dulaglutide biosimilar BA5101 to partner

Reuters
·
Jun 11

Luye Pharma Completes $180 Million Convertible Bond Sale

MT Newswires Live
·
Jun 11

LUYE PHARMA Successfully Issues $180 Million Convertible Notes Due 2031

Stock News
·
Jun 11

Luye Pharma finalises US$180 million 5.25% convertible bond issue maturing 2031

Bulletin Express
·
Jun 11

Hong Kong Stocks Extend Losses Amid Middle East Flare-Up; Luye Pharma Proposes Debt Offering

MT Newswires Live
·
Jun 04

Hong Kong Market Midday Update: Hang Seng Index Down 1.4% as Semiconductor Sector Defies Broader Decline

Stock News
·
Jun 04

Luye Pharma Plans $180 Million Convertible Bond Sale, Bond Buyback

MT Newswires Live
·
Jun 04

FTSE China 50 Index Rebalance Adds GigaDevice, Pony.ai and WeRide Enter Southbound Stock Connect

Stock News
·
Jun 04

Luye Pharma to Repurchase 2028 Convertible Bonds at 103.13% and Issue New US$180 Million 5.25% CBs Due 2031

Bulletin Express
·
Jun 04

Luye Pharma - Proposed Concurrent Repurchase of US$180 Mln 6.25 per Cent. Convertible Bonds Due 2028

THOMSON REUTERS
·
Jun 04

Luye Pharma to Repurchase US$180.00 million 2028 CBs and Launch New USD Convertible Issue

Bulletin Express
·
Jun 03

LUYE PHARMA Announces Concurrent Tender Offer for $180 Million 2028 Convertible Notes and Proposed New USD-Denominated Convertible Bond Issuance

Stock News
·
Jun 03